Agios Pharmaceuticals, Inc. (AGIO)
37.00
-0.19
(-0.51%)
USD |
NASDAQ |
Oct 23, 16:00
37.00
0.00 (0.00%)
After-Hours: 20:00
Agios Pharmaceuticals Gross Profit Margin (Quarterly) : 90.29% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 90.29% |
| March 31, 2026 | 87.07% |
| December 31, 2025 | 84.25% |
| September 30, 2025 | 76.30% |
| June 30, 2025 | 76.23% |
| March 31, 2025 | 72.92% |
| December 31, 2024 | 75.52% |
| September 30, 2024 | 76.26% |
| June 30, 2024 | 64.16% |
| March 31, 2024 | 75.88% |
| December 31, 2023 | 72.00% |
| September 30, 2023 | 69.51% |
| June 30, 2023 | 17.01% |
| March 31, 2023 | 11.71% |
| December 31, 2022 | -11.14% |
| September 30, 2022 | -42.52% |
| June 30, 2022 | 6.68% |
| March 31, 2022 | -531.4% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | 87.47% |
| September 30, 2019 | 82.29% |
| June 30, 2019 | 82.98% |
| March 31, 2019 | 85.36% |
| December 31, 2018 | 91.29% |
| September 30, 2018 | 83.60% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | 0.00% |
| June 30, 2014 | 0.00% |
| March 31, 2014 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 90.81% |
| Biogen, Inc. | 61.37% |
| Insmed, Inc. | 83.71% |
| Alnylam Pharmaceuticals, Inc. | 76.88% |
| Regeneron Pharmaceuticals, Inc. | 83.68% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -34.38% |
| Return on Assets | -31.89% |
| Return on Invested Capital | -33.26% |
| Profit Margin (Quarterly) | -225.1% |
| Operating Margin (Quarterly) | -247.1% |
| Return on Net Operating Assets | -486.9% |